Latest Interviews
Showing 16–18 of 18 transcripts.
Clear all filters- All-In Podcast1h 32m
Massive jobs revision, Kamala wealth tax, polls vs prediction markets, end of race-based admissions
Chamath, Jason, Kamala Harris, Biden, Friedberg, J Cal
Panelists analyzed a historic downward revision of 818,000 jobs in the U.S. labor market, which experts argue signals a shift toward Federal Reserve rate cuts and a dangerous trend of government dependency threatening political stability. The discussion turned to the Supreme Court's affirmative action ruling, where MIT data shows Asian American enrollment rising to 47%, fueling debates on meritocracy versus race-conscious admissions and the value of vocational models like co-op education. Furthermore, the group critiqued the 2024 election landscape, highlighting Nate Silver's "coin toss" polling and the controversy surrounding Harris's proposed 25% tax on unrealized capital gains, which critics warn could trigger capital flight rather than deficit reduction.
- All-In Podcast1h 19m
E148: McCarthy ousted, border chaos, Cruise's robotaxi "accident" & more
McCarthy, Cruise, Jason, Chamath, Calacanis, Friedberg, Webster, Chaffetz, Abbott, Biden, Trump, Adams, David Sacks
The hosts corrected prior financial estimates for Airtable, clarifying its current valuation sits between $7 and $8 billion with approximately $500 million in ARR after consulting CEO Howie Liu. The discussion also detailed Speaker Kevin McCarthy's ousting by a bipartisan vote seeking to replace continuing resolutions with twelve individual spending bills to curb federal debt. Further segments analyzed accelerating U.S. border encounters, advocating for a return to strict asylum vetting and satellite surveillance, while contrasting the public's low risk tolerance for autonomous vehicles against their proven safety potential.
- All-In Podcast1h 43m
E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more
Chamath Palihapitiya and David Sacks led the 2023 All In Summit, discussing personal health optimization, the evolving US political landscape, and a detailed analysis of the recovering IPO market amidst macroeconomic headwinds. The event featured critical assessments of recent venture exits, warnings about "zombie unicorns" facing equity dilution, and significant scientific breakthroughs in autoimmune therapies using inverse vaccines. With a focus on avoiding geopolitical catastrophe and navigating capital scarcity, the summit concluded that market forces will likely impose fiscal restraint rather than legislative action.